NIKKEI 225
27,327.11 -106.29 (-0.39%) HANG SENG
21,842.33 -227.40 (-1.03%) CRUDE OIL
78.94 +1.04 (+1.34%) GOLD FUTURES
1,945.30 +6.10 (+0.31%) DOW
33,869.51 +152.42 (+0.45%) BTC-GBP
18,784.96 -68.69 (-0.36%)
NVO Jan 2024 115.000 put
| Previous close | 4.2000 |
| Open | 4.2000 |
| Bid | 2.1000 |
| Ask | 6.9000 |
| Strike | 115.00 |
| Expiry date | 2024-01-19 |
| Day's range | 4.2000 - 4.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
- Zacks
J&J (JNJ) Down as Court Rejects Bankruptcy Claim in Talc Lawsuits
A federal appeals court rejects J&J's (JNJ) efforts to shift over 38,000 lawsuits related to its talcum-based baby powder out of trial courts and into bankruptcy court.
- Zacks
Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
Sanofi's (SNY) top line is likely to have been driven by higher sales of Dupixent and vaccines.
- Globe Newswire
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 31 January 2023 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programme
